Lincoln Park, NJ, United States of America

Raymundo Claudio

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Enteris Biopharma, Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymundo Claudio. Retrieved from https://idiyas.com/inventor/raymundo-claudio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raymundo Claudio: Innovator in Pharmaceutical Compositions

Introduction

Raymundo Claudio is a notable inventor based in Lincoln Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. His work focuses on enhancing the bioavailability of therapeutic active agents, which is crucial for effective treatment.

Latest Patents

Raymundo Claudio holds a patent for his invention titled "Solid oral dosage forms." This patent provides pharmaceutical compositions suitable for oral delivery of active agents, such as peptides and small molecules. The invention outlines methods for treating subjects in need of these therapeutic agents, emphasizing the enhancement of bioavailability.

Career Highlights

Claudio is currently associated with Enteris Biopharma, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in developing effective drug delivery systems has positioned him as a valuable asset in his field.

Collaborations

Some of his notable coworkers include John Vrettos and Thomas A Daggs. Their collaborative efforts contribute to the advancement of pharmaceutical technologies and the development of new therapeutic solutions.

Conclusion

Raymundo Claudio's work in pharmaceutical compositions exemplifies the importance of innovation in enhancing drug delivery systems. His contributions are vital for improving patient outcomes and advancing the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…